Search Results - "Burrows, Jeremy N."

New developments in anti-malarial target candidate and product profiles.

Authors: Burrows, Jeremy N. Duparc, Stephan Gutteridge, Winston E. et al.

Source: Malaria Journal. 1/13/2017, Vol. 16, p1-29. 29p. 2 Diagrams, 8 Charts, 1 Graph.

This result is not displayed to guests.
Login for full access.

Designing the next generation of medicines for malaria control and eradication.

Authors: Burrows, Jeremy N. Van Huijsduijnen, Rob Hooft Möhrle, Jörg J. et al.

Source: Malaria Journal. 2013, Vol. 12 Issue 1, p1-20. 20p. 4 Diagrams, 7 Charts.

The Open Access Malaria Box: A Drug Discovery Catalyst for Neglected Diseases.

Authors: Spangenberg, Thomas Burrows, Jeremy N. Kowalczyk, Paul et al.

Source: PLoS ONE. Jun2013, Vol. 8 Issue 6, p1-8. 8p.

The global pipeline of new medicines for the control and elimination of malaria.

Authors: Anthony, Melinda P Burrows, Jeremy N Duparc, Stephan et al.

Source: Malaria Journal. 2012, Vol. 11 Issue 1, p316-340. 25p. 4 Diagrams, 4 Charts.

This result is not displayed to guests.
Login for full access.

Glycosidation via conjugate addition of anomeric alkoxides to nitroalkenes and nitrosoalkenes

Authors: Trewartha, Gary Burrows, Jeremy N. Barrett, Anthony G.M.

Source: Tetrahedron Letters: International Organ for the Rapid Publication of Preliminary Communications in Organic Chemistry. May2005, Vol. 46 Issue 20, p3553-3556. 4p.

Subjects: Alkenes, Glycosides, Chemical reactions, Organometallic compounds

Hit and lead criteria in drug discovery for infectious diseases of the developing world.

Authors: Katsuno, Kei Burrows, Jeremy N. Duncan, Ken et al.

Source: Nature Reviews Drug Discovery. Nov2015, Vol. 14 Issue 11, p751-758. 8p. 1 Color Photograph.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Volunteer infection studies accelerate the clinical development of novel drugs against malaria.

Authors: Daubenberger, Claudia Burrows, Jeremy N

Source: Lancet Infectious Diseases. Jun2022, Vol. 22 Issue 6, p753-754. 2p.

Modulators of the human CCR5 receptor. Part 1: Discovery and initial SAR of 1-(3,3-diphenylpropyl)-piperidinyl amides and ureas

Authors: Burrows, Jeremy N. Cumming, John G. Fillery, Shaun M. et al.

Source: Bioorganic & Medicinal Chemistry Letters. Jan2005, Vol. 15 Issue 1, p25-28. 4p.

Screening and hit evaluation of a chemical library against blood-stage Plasmodium falciparum.

Authors: Avery, Vicky M. Bashyam, Sridevi Burrows, Jeremy N. et al.

Source: Malaria Journal. 2014, Vol. 13 Issue 1, p1-26. 26p. 2 Diagrams, 2 Charts, 6 Graphs.

Development and application of a PBPK modeling strategy to support antimalarial drug development.

Authors: Abla, Nada Howgate, Eleanor Rowland‐Yeo, Karen et al.

Source: CPT: Pharmacometrics & Systems Pharmacology. Sep2023, Vol. 12 Issue 9, p1335-1346. 12p.

Identifying a next-generation antimalarial trioxolane in a landscape of artemisinin partial resistance.

Authors: Klope, Matthew T. Talukder, Poulami Blank, Brian R. et al.

Source: Science Advances. 8/8/2025, Vol. 11 Issue 32, p1-10. 10p.

The Parasite Reduction Ratio (PRR) Assay Version 2: Standardized Assessment of Plasmodium falciparum Viability after Antimalarial Treatment In Vitro.

Authors: Walz, Annabelle Duffey, Maëlle Aljayyoussi, Ghaith et al.

Source: Pharmaceuticals (14248247). Feb2023, Vol. 16 Issue 2, p163. 16p.

The Antifungal Itraconazole Is a Potent Inhibitor of Chikungunya Virus Replication.

Authors: Policastro, Lucca R. Dolci, Isabela Godoy, Andre S. et al.

Source: Viruses (1999-4915). Jul2022, Vol. 14 Issue 7, pN.PAG-N.PAG. 12p.

Free radical methodology and approaches to the synthesis of roseophilin

Authors: Burrows, Jeremy N.

URL: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.337602